Race Signs Contract for Phase 1 Trial of RC220
Filed with ASX · · 2 pages · English
Earlier from Racura Oncology
- Quarterly Activity Report and Appendix 4C
- Race Receives $5.25m RD Tax Refund for Financial Year 2024
- Race Submits Human Ethics for RC220 Phase 1 Trial
- Race Discovers Multiple Novel FTO Inhibitor Candidates
- Race Oncology Board Renewal Update
Later from Racura Oncology
- S&P DJI Announces March 2025 Quarterly Rebalance
- Ethics approval received for RC220 Phase 1 Trial
- Race Initiates First AU Site for Phase 1 Solid Tumour Trial
- RC220 Phase 1 Trial Opens for Patient Enrolment
- Enrolment Opened at Second Site for RC220 Phase 1 Trial
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology